Diazepam and Infectious mononucleosis - a phase IV clinical study of FDA data

Summary:

Infectious mononucleosis is reported as a side effect among people who take Diazepam (diazepam), especially for people who are male, 50-59 old, also take Pregabalin, and have Insomnia.

The phase IV clinical study analyzes which people have Infectious mononucleosis when taking Diazepam. It is created by eHealthMe based on reports of 105,904 people who have side effects when taking Diazepam from the FDA, and is updated regularly.

What is Diazepam?

Diazepam has active ingredients of diazepam. It is often used in stress and anxiety. eHealthMe is studying from 108,384 Diazepam users. Check the latest studies of Diazepam.

What is Infectious mononucleosis?

Infectious mononucleosis (infection usually caused by the epstein-barr virus) is found to be associated with 348 drugs and 443 conditions by eHealthMe. Check the latest studies of Infectious mononucleosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

105,904 people reported to have side effects when taking Diazepam.
Among them, 12 people (0.01%) have Infectious mononucleosis.

Could Diazepam cause Infectious mononucleosis?

Among these 12 people:

What is the gender of people who have Infectious mononucleosis when taking Diazepam? *

female: 41.67 %
male: 58.33 %

What is the age of people who have Infectious mononucleosis when taking Diazepam? *

What are other drugs people take besides Diazepam? *

What are other side effects people have besides Infectious mononucleosis? *

Head Injury: 6 people, 50.00%
Memory Loss: 6 people, 50.00%
Fever: 6 people, 50.00%
Fall: 5 people, 41.67%
Hypoaesthesia (reduced sense of touch or sensation): 4 people, 33.33%
Back Pain: 4 people, 33.33%
Speech Impairment (Adult) (inability to speak (adult)): 4 people, 33.33%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 33.33%
Oropharyngeal Pain: 4 people, 33.33%
Pain: 4 people, 33.33%

What are the existing conditions these people have? *

Insomnia (sleeplessness): 3 people, 25.00%
Fever: 2 people, 16.67%
Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 8.33%
Gastric Disorder (disease of stomach): 1 person, 8.33%
Depression: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Diazepam and have Infectious mononucleosis?

- Check whether Infectious mononucleosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diazepam:

Diazepam (108,384 reports)

Browse all side effects of Diazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infectious mononucleosis:

Infectious mononucleosis (348 drugs)

Browse all the conditions that are associated with Infectious mononucleosis:

Infectious mononucleosis (443 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diazepam (the active ingredients of Diazepam) and Diazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.